DA Davidson analyst Linda Bolton Weiser maintains Medifast (NYSE:MED) with a Neutral and raises the price target from $75 to $93.
DA Davidson Maintains Neutral on Medifast, Raises Price Target to $93
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.